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Visual histological assessment of morphological features reflects the underlying molecular
profile in invasive breast cancer: a morphomolecular study
Aims: Tumour genotype and phenotype are related
and can predict outcome. In this study, we hypothe-
sised that the visual assessment of breast cancer (BC)
morphological features can provide valuable insight
into underlying molecular profiles.
Methods and results: The Cancer Genome Atlas (TCGA)
BC cohort was used (n = 743) and morphological fea-
tures, including Nottingham grade and its components
and nucleolar prominence, were assessed utilising
whole-slide images (WSIs). Two independent scores were
assigned, and discordant cases were utilised to represent
cases with intermediate morphological features. Differen-
tially expressed genes (DEGs) were identified for each fea-
ture, compared among concordant/discordant cases and
tested for specific pathways. Concordant grading was
observed in 467 of 743 (63%) of cases. Among concor-
dant case groups, eight common DEGs (UGT8, DDC,
RGR, RLBP1, SPRR1B, CXorf49B, PSAPL1 and
SPRR2G) were associated with overall tumour grade
and its components. These genes are related mainly to
cellular proliferation, differentiation and metabolism. The
number of DEGs in cases with discordant grading was
larger than those identified in concordant cases. The lar-
gest number of DEGs was observed in discordant grade
1:3 cases (n = 1185). DEGs were identified for each dis-
cordant component. Some DEGs were uniquely associ-
ated with well-defined specific morphological features,
whereas expression/co-expression of other genes was
identified across multiple features and underlined inter-
mediate morphological features.
Conclusion: Morphological features are probably related
to distinct underlying molecular profiles that drive both
morphology and behaviour. This study provides further
evidence to support the use of image-based analysis of
WSIs, including artificial intelligence algorithms, to pre-
dict tumour molecular profiles and outcome.
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Introduction
The histological grade of breast cancer (BC) assessed
using the Nottingham Grading System is one of the
strongest prognostic factors in early stage BC.1-4 It
comprises the assessment of morphological features
that represent the degree of similarity between the
tumour and the normal breast parenchymal counter-
parts (i.e. degree of differentiation/de-differentiation)
and the rate of tumour proliferation. It is well known
that histological grade and tumour type reflect under-
lying molecular profiles, which are associated with dis-
tinct genomic features in BC.5-7 Examples of such
tumours include lobular breast carcinoma in which
loss of CDH1 gene function results in a discohesive
growth pattern8 and tall cell carcinoma with reverse
polarity that has isocitrate dehydrogenase 2 (IDH2)
mutations.9-11 Some BC types with unique histological
features also show specific genomic alterations, includ-
ing mucoepidermoid (CRTC3–MAML2 fusion gene),12
secretory (ETV6–NTRK3 fusion gene)13 and adenoid
cystic (MYB–NFIB fusion gene)14 carcinomas.
Gene expression profiling studies of BC have identi-
fied that molecular profile is strongly correlated with
histological grade,5 hormone receptor and human epi-
dermal growth factor receptor 2 (HER2) status.15
However, previous studies which attempted to link the
morphology with the molecular profiles have focused
on the association between the extreme morphological
features (e.g. grades 1 and 3) as an overall measure of
tumour differentiation and the expression of a specific
set of genes. These gene sets were used to stratify
tumours with borderline features (grade 2 tumours)
into two subgroups. This binary approach was also
applied to hormone receptor and HER2 status to strat-
ify tumours into positive and negative for these recep-
tors. In these studies, intermediate values for these bio-
indicators do not define intermediate tumour subsets.
Recently, there has been an increasing interest in
leveraging the power of image analysis and artificial
intelligence (AI) algorithms to identify the various
morphological features of BC from digitalised haema-
toxylin and eosin (H&E) whole-slide images (WSIs)
and to link these features to tumour behaviour,
response to therapy or specific genomic profiles,16
with varying degrees of accuracy.17,18 Validation of
such tools on large multicentric cohorts would allow
the development of image-based tools to predict these
variables in a cost-effective manner. Because the
underlying molecular profiles represent the drivers of
tumour behaviour and can predict response to ther-
apy and determine tumour morphology and sub-
type,19 assessment of these morphological features
can be seen as a surrogate of the underlying molecu-
lar biology of the tumour. However, a detailed associ-
ation between various morphological features and
molecular profiles remains to be defined.
Using the Nottingham Grading System, pathologists
assign BC grade using visual assessment of three mor-
phological features including: (i) tubular differentia-
tion: the spatial arrangement of the cells and
whether they form tubules, as well as the proportion
of tumour cells arranged in such well-formed tubular
structures, (ii) nuclear pleomorphism: departure of
cytonuclear features (such as size, shape and texture)
from those of the normal ductal cell nuclei and (iii)
mitotic count: the number of mitotic figures per 10
high-power fields (thresholds are adapted to account
for field diameter as per the World Health Organisation
classification of tumours of the breast20); this results in an
overall three-tier grading scale. Final tumour grades
are used to predict outcome and guide therapy.3 Due
to its inherent subjective nature, there is some degree
of discordance between independent pathological
assessment of histological grade features, which can
result in some tumours being scored differently by indi-
vidual trained pathologists.3,21,22 However, it is possible
that tumours that are most challenging to be assigned
to a specific grade by all observers reflect intrinsically
different biology and molecular make-up driving their
borderline morphological features. Therefore, character-
ising the distinct molecular features of discordantly
graded tumours may provide further insights into mor-
phomolecular correlations. In addition, other specific
morphological features with prognostic significance,
such as nucleolar prominence,23 need to be investi-
gated to assess not only their correlation with genomic
profiles, but also their relationship with other various
morphological features of BC linked to differentiation,
behaviour and tumour outcome.
In a previous study, we assessed the impact of BC
grade discordance on patients’ outcome.24 In this
study, we hypothesised that subjectivity in grade
assignment of BC is related to the presence of border-
line morphological features which are a reflection of
their underlying genomic and molecular features.
Akin to morphological features, the molecular profiles
of BC represent a spectrum, with some tumours hav-
ing a distinct molecular make-up and hence clearly
defined morphology, while other tumours are in the
borderline zones of these molecular profiles. These
tumours are those which show less distinct morpho-
logical features and overlap between scoring grades.
Deciphering the molecular profiles and genomic fea-
tures of tumours with borderline morphological fea-
tures could, at least in part, explain the discrepancies
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in the level of concordance seen even among expert
well-trained pathologists. This will provide further
evidence to explore the use of computer vision and AI
for assessing morphological features and to further
develop algorithms to extrapolate many variables cor-
related with morphology.
In this study, we have re-assessed the BC cohort
included in The Cancer Genome Atlas (TCGA) data-
base for several morphological features in order to
investigate the relationship between BC grade concor-
dance/discordance, grade components and nucleolar
prominence and the underlying molecular features.
Materials and methods
S T U D Y C O H O R T
A large cohort of BC cases (n = 743) from the TCGA
data set8 (cBioPortal.org) having both RNA sequenc-
ing (RNA-Seq) data and available digital H&E-stained
WSIs scanned at 940 magnification was used in this
study. These data provided access to mRNA expres-
sion from RNASeqV2, along with identified clinico-
pathological factors and outcome. This study focused
on BC grade and nucleolar prominence as the main
histological features assessed for studying the correla-
tion with genomic profiles, whereas the histological
subtype of BC cases included in this cohort (sum-
marised in Supporting information, Table S1) was
not considered in the analysis.
O R I G I N A L G R A D I N G
Original grading of WSIs was carried out by Heng
et al.19 (herein after referred to as the ‘original
grade’), where cases were randomly assigned to
breast pathologists, and the WSIs were graded by
referring to an electronic scoring sheet adapted from
the College of American Pathologists’ (CAP) protocol
for BC grading.20 Grading pathologists held confer-
ence calls to discuss the grading criteria; they then
circulated images for scoring and images with high
consensus diagnoses were used as examples for stan-
dardising grading. The nucleoli scores were assessed
in this study and were assigned a score from 1 to 3
based on their prominence, as previously published.23
Briefly, score 1 was given if nucleoli were inconspicu-
ous and difficult to see at 920 magnification. If the
nucleoli were prominent and easily seen at 910, or
dysmorphic/multiple nucleoli were present, score 3
was assigned. Nucleolar score 2 was assigned to
tumours with nucleoli not scored 1 or 3 (Supporting
information, Figure S1A–C).
R E - S C O R I N G
In this study, all cases were re-scored to reduce the
impact of subjectivity in the assessment of various
morphological features. Concordant cases are consid-
ered to represent cases with distinct morphological
features, whereas discordant cases are likely to repre-
sent cases with intermediate features that are difficult
to assign to one category. Re-grading of these WSIs
(herein after referred to as ‘re-score’) was carried out
by an experienced breast pathologist (L.W.D.) who
previously validated the use of WSIs grade assign-
ment as a predictor of patient outcome.24 He assigned
a second tumour grade by using CAP grading criteria
in BC.20 This was compared to the results obtained
during the original grading, and tumours were
grouped based on the resulting concordant (grades
1:1, 2:2 and 3:3) and discordant (grades 1:2, 1:3 and
2:3) grade assignments, which represent cases with
distinct morphological features and cases with border-
line morphological features, respectively. Examples of
discordant grades 1:2 and 2:3 are shown in Support-
ing information, Figure S1D,E.
Additionally, during re-scoring, other specific mor-
phological features were recorded individually, such as
the mitotic index and nucleolar prominence. For the
standardised assessment of mitotic index using WSIs of
the study cohort, mitotic figures were counted per
mm2. Nucleolar prominence was not initially scored as
a separate feature in the original grade, even though
it is implied in one of the grade components (nuclear
pleomorphism). For the purposes of selecting concor-
dant cases when evaluating this feature during re-
score, it was assessed by two observers (L.W.D. and
K.E.S.), as previously detailed.23
A S S E S S I N G C O N C O R D A N C E A N D I D E N T I F Y I N G
D I F F E R E N T I A L L Y E X P R E S S E D G E N E S ( D E G S )
To expand our understanding of the molecular mech-
anisms underlying grade concordance and discor-
dance that drive both morphology and outcome,
differentially expressed genes (DEGs) were identified.
To do this, a composite score was calculated based on
the scores obtained for a grade, its components and
nucleolar prominence, by the two observers as
described earlier,19,23 to define the concordance/dis-
cordance. To avoid bias, only concordant cases were
used in the analysis to define the DEGs associated
with specific grade, grade components (tubular differ-
entiation, nuclear pleomorphism and mitotic count)
and with nucleolar prominence. Gene expression data
for> 20 000 genes generated by the TCGA BRCA
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Table 1. Concordance rates - The tables show cross comparison (these are also called “confusion matrices” in the machine
learning literature) of TCGA whole slide images assessed for grade (A), grade component scores (B–D) and nucleolar promi-




Total percentage Kappa valueGrade 1 Grade 2 Grade 3
Grade 1 89 57 12 21.3% 0.43
Grade 2 72 179 54 41%
Grade 3 6 75 199 37.7%
Total Percentage 22.5% 41.9% 35.7% 100%
Percent exact agreement: 63%, Percent adjacent level: 35%, Percent high:low: 2%
(B)
Tubular differentiation (Original grade)
Tubular differentiation (Re-score)
Total percentage Kappa valueScore 1 Score 2 Score 3
Score 1 10 53 14 10.4% 0.44
Score 2 0 80 68 19.9%
Score 3 3 41 474 69.7%
Total Percentage 1.7% 23.4% 74.8% 100 %
Percent exact agreement: 76%, Percent adjacent level: 22%, Percent high:low: 2%
(C)
Nuclear Pleomorphism (Original grade)
Pleomorphism (Re-score)
Total Percentage Kappa valueScore 1 Score 2 Score 3
Score 1 23 30 5 7.8% 0.41
Score 2 68 168 99 45.1%
Score 3 4 49 297 47.1%
Total Percentage 12.8% 33.2% 54% 100 %
Percent exact agreement: 66%, Percent adjacent level: 33%, Percent hi:low: 1%
(D)
Mitotic count (Original grade)
Mitotic count (Re-score)
Total Percentage Kappa valueScore 1 Score 2 Score 3
Score 1 293 37 17 46.7% 0.35
Score 2 97 41 36 23.4%
Score 3 41 72 109 29.9%
Total Percentage 58% 20.2% 21.8% 100%
Percent exact agreement: 60%, Percent adjacent level: 32%, Percent high:low: 8%
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study were obtained and patients were stratified based
on the composite score generated for each analysed
component. DEGs were identified using the RobiNA
implementation of the Edge R statistical tool.25,26
Genes were filtered based on fold change (> 2) com-
bined with P-value (<0.05). Common DEGs were
identified between groups using the Venny version 2.0
tool (https://bioinfogp.cnb.csic.es/tools/venny/). These
DEGs were further analysed comparatively between dif-
ferent subgroups of cases. The web-based gene set
enrichment analysis tool (WebGestalt) was used to
calculate significantly enriched pathways and gene
ontologies (GO) based on the identified DEGs.27-29
As the TCGA data have a limited number of events
(disease recurrence or related mortality), outcome
analysis was computed using the Kaplan–Meier (KM)
Plotter data set (n = 1764) as a validation for the
prognostic value of the observed gene signature at
the mRNA level.30 The KM Plotter data set has 1764
cases with recurrence data, while the overall survival
data was available for 626 patients only. The survival
of patients was stratified by the collective mean
Table 1. (Continued)
(E)
Nucleolar prominence score* (1st observer)
Nucleolar Prominence score (2nd observer)
Total Percentage Kappa valueScore 1 Score 2 Score 3
(E)
Nucleolar prominence score* (1st observer)
Nucleolar Prominence score (2nd observer)
Total Percentage Kappa valueScore 1 Score 2 Score 3
Score 1 180 47 3 40.5% 0.4
Score 2 55 96 9 28.2%
Score 3 23 87 68 31.3%
Total Percentage 45.4% 40.5% 14.1% 100%
Percent exact agreement: 61%, Percent adjacent level: 35%, Percent hi:low: 4%
* The nuclear prominence is scored twice in this study by 2 scorers (1st scorer and 2nd scorer) as no original nucleolar score was available
online.
Table 2. Differential gene expression analysis showing the numbers of genes expressed in association with the overall
grade, grade components and nucleolar prominence (Analysis was restricted to the concordant cases)
Differentiation parameter Total differentially expressed Upregulated genes Downregulated genes
Tubular differentiation 595 348 247
Nuclear pleomorphism 728 492 236
Mitotic count 620 543 77
Nucleolar prominence 352 250 102
Overall grade 519 361 158
Grade 1 versus (Grade 2 and Grade 3) 649 249 400*
Grade 2 versus (Grade 1 and Grade 3) 533 388 145
Grade 3 versus (Grade 1 and Grade 2) 589 301 288
*When these 400 down-regulated genes were investigated for enriched pathways, they were significantly enriched within the Integrin sig-
nalling pathway and the top master regulators were COL2A1, COL11A2, COL9A3, DMBT1 and COL9A1.
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mRNA expression of the identified common DEGs.
The best-performing threshold against outcome was
used to categorise the cases into high and low risk
as generated by the KM Plotter (determined by the
public domain database) regardless of the tumour
grade. No mutational analysis was performed in this
study.
S T A T I S T I C A L A N A L Y S I S
BM SPSS version 24.0 (SPSS, Inc., IBM Corp, Chicago,
IL, USA) software was used for statistical analysis.
The concordance rate for assigning tumour grade
and for estimating different grade components
between observers was assessed using the kappa test.
Results
C O N C O R D A N C E A S S E S S M E N T
Concordant grading was observed in 63% of cases
(grades 1:1 in 12%, 2:2 in 24% and 3:3 in 27%),
whereas grade discordance was observed in the
remaining 36% cases (grades 1:2 in 17%, 2:3 in 17%
and 1:3 in 2%). In terms of morphological features,
concordance rates were largely similar: 76% for tubu-
lar differentiation, 66% for nuclear pleomorphism,
60% for mitotic count and 61% for nucleolar promi-
nence (Table 1). The kappa value for concordance
between the two grade assignment sessions (original
grade and re-grade) was 0.43, while for the assess-
ment of each morphological feature kappa values
were as follows: 0.44 for tubular differentiation, 0.41
for nuclear pleomorphism, 0.35 for mitotic count and
0.4 for nucleolar prominence. These values mainly
show a moderate level of agreement.
T R A N S C R I P T O M I C A N A L Y S I S O F C O N C O R D A N C E
A N D G R A D E C O M P O N E N T S
The data analysis for the individual morphological
features assessed in concordant cases (tubular differ-
entiation, nuclear pleomorphism, mitotic count and
nucleolar prominence) identified the following DEG
sets (Table 2):
1. DEGs (595) associated with tubular differentiation,
where 348 genes were significantly up-regulated
with prominent tubular differentiation.

































Downregulated genes associated with Mitotic score.
Downregulated genes associated with Tubule formation
Downregulated genes associated with Nucleolar Prominence.
Mitotic score
Figure 1. The overlap between the down-regulated differentially expressed genes (DEGs) associated with each of grade component in relation
to different grade component (investigated using the Venny tool). The overlap show sets of genes included exclusively in each feature alone,
and in combination, for 40 DEGs included exclusively in mitoses, 15 common DEGs in mitoses and pleomorphism, two common DEGs in
mitoses, pleomorphism and tubule formation, no common DEGs in mitoses, pleomorphism, tubule formation and nucleolar prominence.
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2. DEGs (728) associated with nuclear pleomorphism,
where 492 genes were significantly up-regulated
with high degree of nuclear pleomorphism.
3. DEGs (620) associated with mitotic count, where
543 genes were significantly up-regulated with
high mitotic count.
4. DEG (352) associated with nucleolar prominence,
where 250 genes were significantly up-regulated
with higher nucleolar prominence score.
Sixteen genes were commonly up-regulated across
the four features, whereas no common genes were
down-regulated across the four morphological compo-
nents assessed (Figures 1 and 2). The DEGs associated
with the tumour grade identified 361 genes which
were significantly up-regulated (Table 2). By overlap-
ping the DEGs associated with all four morphological
features (n = 16) with the DEGs associated with the
tumour grade (n = 361), we identified eight core
common genes significantly up-regulated. The Web-
Gestalt over-representation analysis tool (ORA) was
used to perform GO biological process analysis for the
eight significantly up-regulated common genes; this
indicated that some up-regulated genes (PSAPL1,
SPRR1B and SPRR2G) were involved in the epithelial
cell differentiation pathways, whereas other genes
were involved in other related pathways, such as the
sphingolipid metabolic process (PSAPL1 and UGT8)
and the alkaloid metabolic process (DDC). Figures 3
and 4 and Tables 3 and 4 show details of these up-
regulated genes.
A S S O C I A T I O N O F G E N E S I G N A T U R E W I T H
P A T I E N T S ’ O U T C O M E
Within the TCGA cohort; 20% of cases showed high
expression of the eight-gene signature (146 of 743).
To evaluate the clinical value of the eight morphol-
ogy-associated DEGs, we tested them against BC
patient outcome using the KM Plotter database using
default settings with 1764 cases having recurrence
data and 626 with overall survival data.30 High
expression of the eight-gene signature was associated
with shorter overall and recurrence-free survival
(P = 0.003 and P = 0.00016, respectively; Figure 5),
which confirmed the link between morphology,
underlying molecular profiles and outcome.
Nuclear Pleomorphism. Tubule Formation
Nucleolar ProminenceMitotic score
Upregulated genes associated with Nuclear Pleomorphism.
Upregulated genes associated with Mitotic score.
Upregulated genes associated with Tubule formation.































Figure 2. The overlap between the up-regulated differentially expressed genes (DEGs) associated with each morphological feature (investi-
gated using the Venny tool). The overlap, for instance, shows 236 DEGs included exclusively in nuclear pleomorphism, 214 DEGs included
exclusively in mitotic count and 160 DEGs included exclusively in tubular differentiation.
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B I O I N F O R M A T I C S A N A L Y S I S O U T P U T O F G R A D E
D I S C O R D A N T C A S E S
DEGs of grade discordant cases revealed 877 genes
that distinguished grades 1:2 from 1:1 tumours, of
which 491 genes were significantly up-regulated,
including genes associated with the integrin sig-
nalling pathway. Furthermore, there were 1558
genes that differentiated grades 1:3 from 1:1
tumours, involving 768 significantly up-regulated
genes including those associated with the Beta1
adrenergic receptor signalling pathway. Similarly,
there were 955 genes that differentiated tumour
grades 1:2 from 2:2 tumours with 362 up-regulated
genes and including genes significantly associated
with inflammatory pathways mediated by the chemo-
kine and cytokine signalling pathway.
There were 1460 genes that distinguished grades
2:3 from 2:2 tumours having 986 up-regulated genes
and including genes significantly enriched in the plas-
minogen activating pathway. Finally, there were
2346 DEGs that differentiated between grades 2:3
and 3:3 tumours, of which 848 up-regulated genes
were enriched in the heterotrimeric G-protein sig-
nalling pathway-Gq alpha and Go alpha-mediated
pathway. These results are summarised in Table 5,
Supporting information, Table S2 and illustrated in
Figure 6, which is mapped to histological examples of
concordant and discordance cases.
Discussion
Expert visual assessment of tumour morphological
features remains the primary approach to diagnose
and predict BC outcome. The correlation between
morphology and genomic features of BC is also well
documented, and there are several lines of evidence
demonstrating that the distinct behaviour, aggressive-
ness and response to therapy of histological subtypes
of BC are related to distinct molecular alterations.31-
37 In the era of digital pathology, computer-aided
image analysis and image-based AI tools, there is the




Commonalties of differentiall expressed overexpressed genes associated with “Mitoses”, “Pleomorphism”
“,” Tubule formation” and “Nucleoli score”.





Figure 3. The overlap between the up-regulated differentially expressed genes (DEGs) associated with grade component in relation to overall
tumour grade up-regulated DEGs were investigated using the Venny tool. The overlapping has shown eight common up-regulated DEGs in
‘grade component’ and ‘grade’.
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morphology and histology to the underlying molecu-
lar changes within tumours. Kather and colleagues
have recently shown that it is possible to predict the
microsatellite instability of gastrointestinal tumours
by using AI-based morphological features.17 In BC,
Couture et al. also showed that an AI model can pre-
dict the oestrogen receptor (ER) status with more
than 75% accuracy using the histological features
alone.18 Associations between morphological features
and patients’ outcome are strong in BC and, as such,
tumour grade is commonly used to inform treatment
decisions.3 However, concordance among pathologists
in assessing such morphological features is not per-
fect.22 In our study, discordance between assessors
was most common in the assessment of mitotic count
and nucleolar prominence. The subjectivity in identi-
fying the relevant regions within WSIs to assess these
features and the challenges inherent in differentiating
mitotic figures from other similar structures, such as
apoptosis, were probably the main reason for the dis-
cordance, as previously noted.23,38 In addition, the
time interval between case assessments (sometimes
referred to as the ‘wash-out period’) and the large
number of cases included in the study may have con-
tributed discordant assessment in some cases, includ-
ing the rare examples of extreme discordance, such
1:3 and 3:1 grade assignment.
As one of the main aims of this study was to relate
specific morphological features with their underlying
molecular characteristics, only cases with concordant
scoring were considered in the analysis for such cor-
relations. Discordant groups were used to assess the
molecular features of cases with intermediate mor-
phological features. Unlike our previous study of BC
grade concordance that utilised WSIs of cases
assessed at 920 magnification,24 the slides used in
the current study were assessed at 940 magnifica-
tion. However, the proportion of cases with grade
concordance/discordance was similar in both studies,
implying that the scanner magnification has a limited
contribution to the grade concordance.
In a previous study, we demonstrated that cases
with grade discordance were associated with distinct































Figure 4. Pathway analysis using category ‘biological process’ of gene ontology for the eight genes with significant up-regulation across all
specific morphological features investigated (grade components and nucleolar prominence) and overall tumour grade. Cellular differentiation,
metabolism and proliferation are the main ontologies observed.
© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd, Histopathology
Morphomolecular correlates in breast cancer 9
Table 3. The Biological process category by the Gene Ontology Consortium shows the common biological processes that
are significantly associated with grade, grade components and nucleolar prominence
Gene Set Description Size/Overlap* Expect† Ratio/P-value‡ Gene symbol
GO:0070268 Cornification 111/ 2 0.047 42.89/0.001 SPRR1B, SPRR2G
GO:0030855 Epithelial cell differentiation 747/3 0.314 9.56/0.003 PSAPL1, SPRR1B, SPRR2G
GO:0042435 Indole-containing compound biosynthetic process 5/1 0.002 476.11/0.002 DDC
GO:1901162 Primary amino compound biosynthetic process 5/1 0.002 476.11/0.002 DDC
GO:0009820 Alkaloid metabolic process 7/1 0.004 340.08/0.003 DDC
GO:0006665 Sphingolipid metabolic process 153/2 0.064 31.12/0.002 PSAPL1, UGT8
GO:0002175 Protein localization to paranode region of axon 5/1 0.002 476.11/0.002 UGT8
GO:0006682 Galactosylceramide biosynthetic process 6/1 0.002 396.76/0.002 UGT8
GO:0019375 Galactolipid biosynthetic process 6/1 0.002 396.76/0.002 UGT8
GO:0030913 Paranodal junction assembly 7/1 0.004 340.08/0.003 UGT8
*The category size is calculated based on the number of overlapping genes between the annotated genes in the category and the reference
gene list for the “ORA” method. The category overlap is the overlapping between the genes in the input and those in the database.
†The category expect is the number of categories expected from set cover” indicates the number of the expected reduced sets of the
weighted set cover algorithm for redundancy reduction in the report.
‡The category ratio is the enrichment ratio (for ORA) as it indicates the gene ontology sets with FDR < 0.05. The category P value is indica-
tive of the weighted set cover and maximum coverage called size-constrained weighted set cover where weights are assigned to gene sets
with smaller enrichment P values.
Table 4. Differential gene expression analysis of the overall grade, grade components and nucleolar prominence detailing
the 8 most common upregulated genes
Gene description Gene ID Function
1 UDP glycosyltransferase 8 UGT8 Catalyses the transfer of galactose to ceramide, a key enzymatic step in the
biosynthesis of galactocerebrosides.
2 Dopa decarboxylase DDC Catalyses the decarboxylation of L-3,4- dihydroxyphenylalanine (DOPA) to dopamine,
L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine.
3 Retinal G protein coupled
receptor
RGR Receptor for all-trans- and 11-cis-retinal. Binds preferentially to the former
and may catalyse the isomerization of the chromophore by a retinochrome-like
mechanism; Opsin receptors.
4 Retinaldehyde binding protein 1 RLBP1 Soluble retinoid carrier essential for the proper function of both rod and
cone photoreceptors.
5 Small proline rich protein 1B SPRR1B Function as both amine donor and acceptor in transglutaminase-mediated
cross-linkage; Belongs to the cornify (SPRR) family.
6 Chromosome X open reading
frame 49B
CXorf49B Uncharacterised protein CXorf49.
7 Prosaposin like 1 (gene:
pseudogene)
PSAPL1 May activate the lysosomal degradation of sphingolipids.
8 Small proline rich protein 2G SPRR2G A keratinocyte protein that first appears in the cell cytosol, but ultimately becomes
cross-linked to membrane proteins by transglutaminase. All that results in the
formation of an insoluble envelope beneath the plasma membrane.
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probably a reflection of biologically, and hence mor-
phologically, distinct tumours.24 In this study, we
aimed to assess the impact of the underlying molecu-
lar profiles on tumour morphology, the ability of
pathologists to assess them and to evaluate whether
cases with discordant grading have distinct molecular
profiles.
When the concordant/discordant cases are taken
into account, BC grade could be regarded as a five-
category risk scale24 [three concordant (1:1, 2:2, 3:3)
and two discordant (1:2 and 2:3) grade categories]
that are associated with specific genomic/molecular
profiles. Grade 1 concordant cases represent the very
well-differentiated, lowest-risk group of cancers at one
end of the differentiation continuum, whereas grade
3 concordant cases are the least-differentiated
tumours at the other end of the spectrum. In this
study, we used the TCGA BC cohort, which is a pub-
licly available resource that has WSIs for a large
cohort of BC together with their linked molecular,
genetic and de-identified clinical data, to assess the
molecular differences between cases that were con-
cordantly/discordantly graded between experienced
breast pathologists. As expected, the number of DEGs
in concordant cases is much smaller than the num-
ber of DEGs seen with discordant cases. This proba-
bly reflects that concordant cases possess
unambiguously similar morphological features,
whereas discordant cases harbour subtle distinct
morphological features. It also supports the hypothe-
sis that discordant cases reflect intrinsically,
although subtly, different tumour morphological fea-
tures and, by inference, different tumour molecular
characteristics, and that discordance is not simply
the result of subjectivity of eyeballing assessment of
such morphological features.
Regarding the genes that were differentially
expressed in association with various morphological
features used as grade components, a significant over-
lap between genes associated with nuclear pleomor-
phism, nucleolar prominence and cellular
proliferation was identified. This could reflect the
underlying biology of BC in terms of tumour differen-
tiation and proliferation and provide insight regarding
how this is reflected in the morphological features
recorded with the conventional grading of BC. The
results of this study indicated that grade 1 tumours
were enriched with the integrin signalling pathway,
which is important for the functional differentiation
of the epithelia. Grade 2 tumours were enriched with
the heterotrimeric G-protein signalling pathway-Gi
alpha and Gs alpha-mediated pathways, which regu-
late a range of endothelial cell functions including dif-
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Figure 5. Kaplan–Meier survival plot showing association of the identified gene signature (patients were stratified by the cumulative mean
mRNA expression of the identified eight-gene signature) with overall survival (A) and recurrence-free survival (B). A, The survival was sig-
nificantly worse in 252 patients harbouring high expression of the identified eight-gene signature in comparison to 374 patient harbouring
lower expression; B, 444 patients harbouring high expression of the identified eight-gene signature had worse recurrence-free survival in
comparison to 1320 patients harbouring lower expression of the gene signature.
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master regulator genes being CBP2, FGA, FGB, FGG
and MMP1. Finally, grade 3 tumours were enriched
with the Wnt signalling pathway whose overactiva-
tion triggers the oncogenic transformation and prolif-
eration of many cancers, including triple-
negative breast cancers. Some pathways, such as the
Wnt-, CCKR- and cadherin-signalling pathways, were
involved in driving multiple morphological features of
differentiation, whereas other pathways are more
frequently activated in the discordant cases (those
with borderline features), such as the plasminogen
activating cascade, nicotine degradation and iono-
trophic glutamate receptor pathways. Moreover, the
main pathways detected with grade-discordant cases
can be summarised under two main categories which
are related to cellular proliferation and differentiation.
Our study also identified a gene signature comprising
eight up-regulated genes overlapped between the four
Table 5. Number of differentially expressed genes and the top regulated pathway associated with grade concordance/dis-
cordance as defined by both differential gene expression and pathway analyses.28
Differentiation parameter Total DEG Top regulated pathway
Unique genes underlying concordance grades
Grade 1 versus (Grade 2 and Grade 3) 649 Integrin signalling pathway
Grade 2 versus (Grade 1 and Grade 3) 533 Heterotrimeric G-protein signalling pathway-Gi alpha and Gs alpha
mediated pathway
Grade 3 versus (Grade 1 and Grade 2) 589 Wnt signalling pathway
Unique genes underlying discordance grades
Grade 1:2 versus Grade 1 877 Integrin signalling pathway
Grade 1:3 versus Grade 1 1558 Beta1 adrenergic receptor signalling pathway
Grade 2:1 versus Grade 2 955 inflammatory pathways mediated by chemokine and cytokine signalling
pathway
Grade 2:3 versus Grade 2 1460 plasminogen activating pathway
Grade 2:3 versus Grade 3 2346 Heterotrimeric G-protein signalling pathway-Gi alpha and Gs alpha
mediated pathway
Common genes underlying concordance and discordance grades
Grade 1 versus Grade 1:2 365 Nicotine degradation pathway
Grade 1 versus Grade 1:3 0 –
Grade 1:2 versus Grade 1:3 89 Adenine and hypoxanthine salvage pathway
Grade 1 versus Grade 1:2 versus Grade 1:3 284 Adrenaline and noradrenaline
Grade 2 versus Grade 2:1 67 Vitamin D metabolism pathway
Grade 2 versus Grade 2:3 121 Arginine biosynthesis pathway
Grade 2 versus Grade 2:1 versus Grade 2:3 111 Plasminogen activating cascade pathway
Grade 2:1 versus Grade 2:3 403 Heterotrimeric G-protein signalling pathway-rod outer segment
phototransduction pathway
Grade 3 versus Grade 3:2 93 Heterotrimeric G-protein signalling pathway-Gi alpha and Gs alpha
mediated pathway
Grade 3 versus Grade 3:1 122 Muscarinic acetylcholine receptor 1 and 3 signalling pathway
Grade 3 versus Grade 3:2 versus Grade 3:1 110 Inflammatory pathways mediated by chemokine and cytokine signalling
pathway
Grade 3:2 versus Grade 3:1 1574 Nicotine degradation pathway
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morphological features assessed. Up-regulation of one
of this gene signature (UGTB; the endoplasmic reticu-
lum-localised enzyme UDP-galactose:ceramide galac-
tosyltransferase), was related to poor prognosis and
was strongly associated with grade 3 BC.39
Consistent with the differences in tumour beha-
viour and outcome associated with distinct tumour
grades, pathway analysis revealed that the DEGs
identified are related to cellular proliferation and dif-
ferentiation. Our findings also showed that the discor-
dant cases in the grade categories 1:2 or 2:3 had
more complex transcriptional profiles than concor-
dant cases, and that the highest number of DEGs
were seen in tumours showing the extreme ends of
discordance (tumour with grades 1:3 or 3:1). This
supports the hypothesis that the distinct morphologi-
cal features assessed in BC grading are mirroring
underlying molecular mechanisms. As the molecular
make-up of tumours rather than the morphology per
se is the driver of the behaviour, the associations
between morphology and outcome should be
explained by the underlying molecular profile which
determines both, as previously described.24 This is
supported by our findings, where the cases that
showed high expression of the DEGs associated with
grade, and its various components, had a worse out-
come than those with lower expression.
Interestingly, this study identified specific pathways
and gene sets that are associated with specific mor-
phological features. We also reported that some of
these alterations may result in borderline morphologi-
cal features that are difficult to be robustly assigned to
a grade category when using visual assessment alone.
Although the current study has limitations, it provides
a proof of principle and further evidence to support the
use of image analysis methods, including AI-based
tools, in BC diagnosis, the prediction of tumour out-
come and response to therapy. Validation of these
results using independent cohorts and emerging com-
putational approaches will provide more insights into
the pathways associated with each histological feature.
F U T U R E P E R S P E C T I V E S
Developers of image-based AI tools should be aware
of the challenges of grade assignment, and in particu-
lar note that existing grade categories elide subtle dis-
tinct morphological features that are associated with
distinct molecular characteristics and outcomes. Our
understanding of this diversity of molecular pheno-
types resulted from relatively recently developed next-
generation sequencing technologies, as their wider
application to large BC patient cohorts has enabled a
better understanding of the complex biology


















































Figure 6. Overlapping differentially expressed genes (DEGs) between concordant and discordant cases. A, Overlapping DEGs between grades
1:1, 1:2 and 1:3 groups of cases. B, Overlapping DEGs between grades 2:2, 2:1 and 2:3 groups of cases. C, Overlapping DEGs between
grades 3:3, 3:2 and 3:1 groups of cases. Examples of histological images of concordant and discordant cases are mapped adjacent to each
category.
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underlying these histological features. Indeed, the fur-
ther results obtained here highlighted how informa-
tive is tumour morphology. With advances in the
application of image-based AI and machine-learning
techniques to histopathology, it should be possible to
infer underlying genetic and transcriptional pheno-
types from morphological features and thereby more
accurately guide therapies. Thus, AI-based histologi-
cal analyses are likely to build upon this current
study to enable superior patient stratification and
more accurately predict molecular status and clinical
outcomes, as such approaches will leverage the inte-
gration of large complex molecular data sets and
pixel-level image analysis with the identification of
morphological and architectural features not dis-
cernible during visual histological assessment.
Conclusion
This study shows that the underlying molecular alter-
ations in BC are reflected in the morphological features
of tumours and that grade-discordant cases have dif-
ferent genetic signatures when compared with the
grade-concordant ones. It should also show that these
underlying molecular differences have a role in disease
outcome. Such observations could be used to under-
stand the biology of BC of various grades, and could
also provide a tool to better predict the behaviour of
these tumours from their morphological features.
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Additional Supporting Information may be found in
the online version of this article:
Figure S1. Photo micrographic examples of nucleo-
lar scores and grade discordance. (A) inconspicuous
nucleoli, (B) occasional conspicuous nucleoli, (C)
prominent nucleoli easily seen, (D) example of grade
1:2 discordance and (E) example of grade 2:3 discor-
dance.
Table S1. Distribution of various histological breast
cancer histological subtypes in the TCGA dataset and
included in the study.
Table S2. Differentially expressed genes and the top
regulated pathway in association with the grade com-
ponents and nucleolar prominence (concordant cases)
defined by differential gene expression, and Gene set
enrichment analysis (GSEA)/ pathway analysis.
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